🇺🇸 FDA
Patent

US 9701661

2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

granted A61KA61K31/506A61P

Quick answer

US patent 9701661 (2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase) held by Northwestern University expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/506, A61P, A61P25/00, A61P25/28